ASAM developed the National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use to provide information on evidence-based treatment of opioid use disorder.
What is the ASAM National Practice Guideline?
The ASAM National Practice Guideline is the first of its kind to address all FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.
Pocket Guide and App
Official ASAM National Practice Guideline quick-reference tools provide healthcare providers with instant access to current guideline in a clear concise format.
The ASAM National Practice Guideline Slide Deck is a PowerPoint presentation on the guideline with notes from the speaker.
JAM Article The Journal of Addiction Medicine features an article on the National Practice Guideline by Kyle Kampman, MD and Margaret Jarvis, MD, FASAM.
Complete ASAM Guideline
The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use in journal format.
ASAM will be offering continuing medical education (CME) webinars on the National Practice Guideline.
Promotion Tool Kit
Tools, messages and banners to help us promote the guidelines beyond our reach.
National Press Club - September 24th 2015
Join ASAM today
Sign up now
©2016 American Society of Addiction Medicine. All rights reserved.
5515 Security Lane, Suite 700, North Bethesda, MD 20852